Loading…

A novel full-human CD22-CAR T cell therapy with potent activity against CD22 low B-ALL

Saved in:

Bibliographic Details
Published in:	Blood cancer journal (New York) 2021-04, Vol.11 (4), p.71
Main Authors:	Tan, Yue, Cai, Haodong, Li, Chuo, Deng, Biping, Song, Weiliang, Ling, Zhuojun, Hu, Guang, Yang, Yongkun, Niu, Panpan, Meng, Guangrong, Cheng, Wei, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Yu, Xinjian, Feng, Xiaoming, Zhou, Jianfeng, Pan, Jing
Format:	Article
Language:	English
Subjects:	Adolescent Animals Antineoplastic Agents, Immunological - adverse effects Antineoplastic Agents, Immunological - therapeutic use Child Child, Preschool Humans Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Jurkat Cells K562 Cells Mice Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy Receptors, Chimeric Antigen - therapeutic use Sialic Acid Binding Ig-like Lectin 2 - antagonists & inhibitors Sialic Acid Binding Ig-like Lectin 2 - immunology Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!